BWV Onconetix Inc


$ 3.38 $ -0.08 (-2.29 %)    

Thursday, 23-Oct-2025 18:50:44 EDT
QQQ $ 611.70 $ 5.09 (0.84 %)
DIA $ 467.20 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.38 $ -0.63 (-0.68 %)
GLD $ 378.90 $ 1.51 (0.4 %)
$ 3.3515
$ 3.44
$ 3.25 x 100
$ 3.84 x 50
$ 3.31 - $ 3.52
$ 2.45 - $ 442.00
10,083
na
na
$ 2.39
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 blue-water-biotech-acquires-proteomedix-ag-a-private-commercial-stage-diagnostics-oncology-company-in-stock-consideration-no-terms-disclosed

The acquisition of Proteomedix for all stock consideration provides its shareholders with an initial 19.9% ownership stake of O...

 why-nxu-shares-are-trading-higher-by-around-42-here-are-20-stocks-moving-premarket

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining inv...

Core News & Articles

https://www.reuters.com/business/healthcare-pharmaceuticals/who-very-worried-about-spread-mpox-drc-2023-12-08/?taid=65734f21df0...

 blue-water-biotech-signed-non-binding-term-sheet-to-acquire-a-commercial-stage-oncology-company

https://www.sec.gov/Archives/edgar/data/1782107/000121390023082344/ea187618ex99-1_bluewater.htm

 stocks-that-hit-52-week-lows-on-tuesday

  Tuesday saw 132 companies set new 52-week lows.

 blue-water-biotech-appoints-dr-neil-j-campbell-as-president-and-ceo-and-bruce-harmon-as-cfo

Blue Water Biotech, Inc. (NASDAQ:BWV), which is focused on developing and commercializing transformational therapies to address...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 386 stocks made new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION